Internet Explorer 8 Warnung Anscheinend verwenden Sie einen älteren Internet Explorer. Leider unterstützen wir, genau wie Microsoft, diesen Browser nicht mehr. Sie werden also Fehlermeldungen und ein inkonsistentes Design erleben.
Bitte haben Sie Verständnis und entschuldigen Sie die Unannehmlichkeiten.
Logo HTGF

News

High-Tech Gründerfonds and DocCheck AG Guano invest in heartbeat medical

Patient reported outcomes and intelligent treatment analytics: heartbeat medical, a Berlin and Cologne based startup, enables doctors to measure and improve their procedures. The High-Tech Gründerfonds, Germany’s largest seed investor, and the DocCheck Guano AG invest a high six figure-number into the emerging startup.

With heartbeat ONE the general health and healing process of patients can be tracked even years after an actual intervention. Patients get digital questionnaires, which they can answer comfortably at home or on the go. Participating physicians also use the software to document their surgical procedures extensively. Subsequently, the information from the doctor and the patient reported outcome measures are combined, analysed and patterns visualized. In addition to anticipated medical findings, this will also help to strengthen confidence between doctor and patient and continue.

heartbeat medical was founded in early 2014 with a first investment by business angels. Within the last two years, the four founders Yannik Schreckenberger, Marc Tiedemann, Sebastian Tilch and Yunus Uyargil managed to establish a platform matching high requirements on privacy protection and data security. As of today it is in use at five health care facilities.

“We are delighted to see the HTGF and DocCheck Guano AG on board as strong strategic partners,“ says Yannik Schreckenberger, CEO of heartbeat medical, “Now we can concentrate on further development of heartbeat ONE and position it as the leading system for quality assurance of therapies.” The investment will be used for hiring new developers and building a distribution channel. In addition, a large multicentre study is planned for later this year.

Dr. Philipp Rittershaus, Investment Manager at High-Tech Gründerfonds confirms: “With heartbeat ONE it is possible to measure patient related outcomes and document medical interventions. The medical data is then directly available to help analyze processes, control and improve.”

Contact:
Marc Tiedemann
EMail: tiedemann@heartbeat-med.de
https://one.heartbeat-med.de
Phone: +49 30 120 76470

HRTBT Medical Solutions GmbH
Brunnenstr. 181
10119 Berlin

Press-Kit: bit.ly/1PgSUxC

heartbeat ONE
heartbeat ONE provides a streamlined patient management tool for health care facilities of all sizes. It offers intelligent evaluations of diagnostics and treatment methods. It supports the preparation, documentation and evaluation of medical interventions. Patient reported outcomes can automatically be collected for every patient. heartbeat ONE is hosted for customers in certified data centers in Germany or if desired self hosted on site. Fully web-based the system heartbeat ONE runs on all major operating systems and requires only a modern browser. The integrated medical documentation has been enhanced by an algorithm that dynamically adapts to the treatment situation. In order to conduct patient surveys and a digital anamnesis via tablet at cite, native applications for iOS and Android platforms are available. Follow-up patient surveys are carried out over a separate patient portal which can be accessed from all devices (pc, smartphone, tablet, etc.).

DocCheck Guano AG
DocCheck Guano AG provides innovative healthcare startups with the best nutrients possible: capital, know-how and market access. Commercial understanding meets creative freedom: the great minds behind Guano are thrilled to work with committed entrepreneurs for mutual inspiration. With their many years of experience in the healthcare sector and in business management, Guano offers startups the breeding ground they need in the first years. Guano is always seeking fresh ideas and highly motivated makers from the entrepreneur scene.

High-Tech Gründerfonds
High-Tech Gruenderfonds invests in young, high potential high-tech start-ups. The seed financing provided is designed to enable start-ups to take an idea through prototyping and to market launch. Typically, High-Tech Gruenderfonds invests EUR 600,000 in the seed stage, with the potential for up to a total of EUR 2 million per portfolio company in follow-on financing. Investors in this public/private partnership include the Federal Ministry of Economics and Energy, the KfW Banking Group, as well as strategic corporate investors including ALTANA, BASF, Bayer, B. Braun, Robert Bosch, CEWE, Daimler, Deutsche Post DHL, Deutsche Telekom, Evonik, Lanxess, media + more venture Beteiligungs GmbH & Co. KG, METRO, Qiagen, RWE Innogy, SAP, Tengelmann and Carl Zeiss. High-Tech Gruenderfonds has about EUR 576 million under management in two funds (EUR 272 million HTGF I, EUR 304 million HTGF II).

Contact:
High-Tech Gründerfonds Management GmbH
Dr. Philipp Rittershaus
Schlegelstraße 2 | 53113 Bonn
Phone: +49 228 823001-33 | Fax: +49 228 823000-50 | EMail: p.rittershaus@htgf.de
www.high-tech-gruenderfonds.de